Mitochondrial myopathy associated with anti-programmed cell death 1 therapy

We present two cases of patients with metastatic melanoma who developed secondary mitochondrial myopathy which was suspected to be induced by anti-PD1 monoclonal antibodies (mAb).

Source: European Journal of Cancer - February 13, 2019 Category: Cancer & Oncology Authors: Tony Ibrahim, Clovis Adam, Emilie Routier, Abdelhamid Slama, Caroline Robert Tags: Letter to the Editor Source Type: research